Microsoft, Astrazeneca Launches AI Factory for Health Accelerator in Europe

微软公司和阿斯利康在欧洲推出AI Factory for Health加速器

2019-09-09 16:33:24 HIT Consultant

本文共1184个字,阅读需3分钟

– Microsoft and AstraZeneca are joining forces to launch the AI Factory for Health, a European accelerator for AI-focused digital health startups. – The 3-month accelerator program is for startups that offer an innovative health solution based on artificial intelligence technology for patients or health professionals – Created by Microsoft in partnership with the Inria laboratory, the AI Factory unites a community of startups dedicated to the development of innovative solutions based on Artificial Intelligence. On Thursday, Microsoft and AstraZeneca announced they are joining forces to launch the AI Factory for Health, a European accelerator for AI-focused digital health startups. The three-month accelerator is designed to continue their development in artificial intelligence, cloud computing to push the boundaries of science. AI Factory for Health Background Created by Microsoft in partnership with the Inria laboratory, the AI Factory is a co-innovation laboratory that links startups, the research world and the various players in the sector. Through these synergies, the AI ​​Factory for Health projects will serve the patients and the medical profession to offer a renewed and individualized medicine. Startups selected to join the AI Factory for Health will benefit from AstraZeneca’s know-how and expertise in pathologies, knowledge of patient needs and healthcare professionals, as well as legal expertise, access to institutions, and health data for the different European countries in which AstraZeneca operates. From mentoring to technical advice on their solutions to recommendations for promotion and marketing as part of a co-marketing or co-selling approach. Microsoft provides each start-up with personalized support at every stage of their growth. In addition, Microsoft will bring its technological expertise and services from the Azure platform as well as personalized support, particularly via its commercial network. The Bigger Picture Many practices in health and in the development of therapeutic solutions are, at the moment, transformed by the digital technology, making it possible to position the patient at the heart of this device, and thus to propose a truly individualized medicine. Artificial intelligence (AI), machine learning, big data, and automation improve the patient’s journey from prevention to treatment, diagnosis and quality of life. Thanks to a more precise and regular follow-up of the effects of the drugs or digital companions likely to answer the questions which were not put to the medical team, the patients approach their care more serenely, in the hospital as at home. “At AstraZeneca, putting patients first is the fundamental value that guides us in everything we do. We believe that by deepening our understanding of diseases, patient expectations and experiences, we can further improve their quality of life. We also believe that putting patients at the heart of the health care system is a collective effort that draws on the expertise and skills of new partners. That’s why I’m really excited that the AstraZeneca and Microsoft teams are joining forces and laying the foundation stone for their collaboration with AI Factory for Health, ” says Iskra Reic, EVP Europe & Canada, AstraZeneca. Startup Submission and Criteria The open application period is now open until October 31st. Startups who want to join the program must: Offer an innovative health solution based on artificial intelligence technology for patients or health professionals – First fundraising: Seed or Series A, or equivalent phase of development. Up to $3M in funding. (Funding information must be verified.) – Mature project: The startup must be engaged in the development of a software-based product or service that will form a core piece of the current or intended business. – Already on market: The startup must be engaged on a deployment with at least a minimum of one customer – Promising Team: Common Values & Vision
–微软和阿斯利康正联手推出面向健康的人工智能工厂,这是面向人工智能数字健康初创企业的欧洲加速器。 –为期3个月的加速器项目面向为患者或健康专业人士提供基于人工智能技术的创新健康解决方案的初创企业 –人工智能工厂由微软与Inria实验室合作创建,它将致力于开发基于人工智能的创新解决方案的初创企业社区联合起来。 周四,微软和阿斯利康宣布,他们将联手推出面向人工智能的数字健康初创企业的欧洲加速器“健康人工智能工厂”。这项为期三个月的加速器旨在继续其在人工智能、云计算方面的发展,以推动科学的边界。 卫生背景人工智能工厂 这家人工智能工厂是由微软与inria实验室合作创建的,是一个联合创新实验室,将初创企业、研究界和该领域的各个参与者联系在一起。通过这些协同作用,医疗项目人工智能工厂将为患者和医疗行业提供更新和个性化的药物。 被选中加入人工智能健康工厂的初创企业将受益于阿斯利康在病理学、患者需求知识和医疗专业人员方面的专业技能和专业知识,以及阿斯利康所在的不同欧洲国家的法律专业知识、机构访问权和健康数据。Razeneca在运作。 从对他们的解决方案的指导到技术建议,再到作为共同营销或共同销售方法一部分的促销和营销建议。微软为每一个初创企业在成长的每个阶段提供个性化的支持。此外,微软还将从azure平台带来其技术专长和服务以及个性化支持,特别是通过其商业网络。 大局 目前,在健康和治疗方案开发方面的许多实践正在被数字技术所改变,使得能够将患者定位在该设备的核心,从而提出一种真正个性化的药物。人工智能、机器学习、大数据和自动化改善了患者从预防到治疗、诊断和生活质量的旅程。由于对药物或数码伴侣的影响进行了更精确和定期的跟踪,这些药物或数码伴侣可能会回答未提交给医疗团队的问题,因此患者在医院和在家一样,更平静地接受治疗。 “在阿斯利康,把病人放在第一位是指导我们做任何事情的基本价值。我们相信,通过加深对疾病、病人期望和经历的了解,我们可以进一步提高他们的生活质量。我们还认为,将患者置于医疗体系的核心是一项集体努力,它利用了新伙伴的专业知识和技能。这就是为什么我真的很兴奋,阿斯利康和微软车队正在联合力量,奠定了基石,他们与人工智能工厂的健康合作,说:“Iskra Reic,EVP欧洲和加拿大,阿斯利康。 启动提交和条件 开放申请期现在开放至10月31日。想要加入该计划的初创企业必须: 为患者或健康专业人士提供基于人工智能技术的创新健康解决方案 -第一次筹款:种子或系列A,或同等发展阶段。高达300万美元的资金。(必须核实资金信息。) –成熟项目:初创企业必须从事基于软件的产品或服务的开发,该产品或服务将构成当前或预期业务的核心部分。 –已经上市:初创企业必须至少有一个客户参与部署 –有前途的团队:共同价值观和愿景

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文